Does ROSIGLITAZONE Cause Stent placement? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Stent placement have been filed in association with ROSIGLITAZONE. This represents 0.4% of all adverse event reports for ROSIGLITAZONE.
196
Reports of Stent placement with ROSIGLITAZONE
0.4%
of all ROSIGLITAZONE reports
11
Deaths
156
Hospitalizations
How Dangerous Is Stent placement From ROSIGLITAZONE?
Of the 196 reports, 11 (5.6%) resulted in death, 156 (79.6%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does ROSIGLITAZONE Cause?
Myocardial infarction (17,018)
Cardiac failure congestive (15,085)
Cerebrovascular accident (7,899)
Coronary artery disease (4,982)
Acute myocardial infarction (2,437)
Cardiac disorder (1,732)
Coronary arterial stent insertion (1,698)
Coronary artery bypass (1,181)
Chest pain (990)
Myocardial ischaemia (970)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
FLUTICASONE\SALMETEROL (105)
Which ROSIGLITAZONE Alternatives Have Lower Stent placement Risk?
ROSIGLITAZONE vs ROSUVASTATIN
ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN
ROSIGLITAZONE vs ROTIGOTINE
ROSIGLITAZONE vs ROXADUSTAT
ROSIGLITAZONE vs ROXICODONE